1452PCombination of the S49076 with gefitinib in NSCLC patients progressing on EGFR-TKI and harboring MET/AXL dysregulation. (23rd October 2018) - Viteri, S; Chang, G-C; Chiari, R; Cho, B C; Ciardiello, F; Curigliano, G; Hida, T; Lee, D H; Lim, W T D; Lin, C-C; Martinez, A; Murakami, H; et al.